tradingkey.logo
tradingkey.logo
Search

cbdMD Inc

YCBD
Add to Watchlist
0.685USD
+0.000+0.03%
Close 07/02, 13:00ETQuotes delayed by 15 min
7.19MMarket Cap
0.02P/E TTM

TradingKey Stock Score of cbdMD Inc

Currency: USD Updated: 2026-07-02

Key Insights

cbdMD Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 105 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.00.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

cbdMD Inc's Score

Industry at a Glance

Industry Ranking
105 / 157
Overall Ranking
305 / 4565
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

cbdMD Inc Highlights

StrengthsRisks
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.19M.
Overvalued
The company’s latest PE is 0.02, at a high 3-year percentile range.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
2.000
Target Price
+194.16%
Upside Space

FAQs

How does TradingKey generate the Stock Score of cbdMD Inc?

The TradingKey Stock Score provides a comprehensive assessment of cbdMD Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of cbdMD Inc’s performance and outlook.

How do we generate the financial health score of cbdMD Inc?

To generate the financial health score of cbdMD Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects cbdMD Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of cbdMD Inc.

How do we generate the company valuation score of cbdMD Inc?

To generate the company valuation score of cbdMD Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare cbdMD Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of cbdMD Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of cbdMD Inc.

How do we generate the earnings forecast score of cbdMD Inc?

To calculate the earnings forecast score of cbdMD Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on cbdMD Inc’s future.

How do we generate the price momentum score of cbdMD Inc?

When generating the price momentum score for cbdMD Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of cbdMD Inc’s prices. A higher score indicates a more stable short-term price trend for cbdMD Inc.

How do we generate the institutional confidence score of cbdMD Inc?

To generate the institutional confidence score of cbdMD Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about cbdMD Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of cbdMD Inc.

How do we generate the risk management score of cbdMD Inc?

To assess the risk management score of cbdMD Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of cbdMD Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of cbdMD Inc.